A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy

被引:6
|
作者
Li, Minying [1 ]
Zhang, Jingjing [1 ]
Zha, Yawen [1 ]
Li, Yani [1 ]
Hu, Bingshuang [1 ]
Zheng, Siming [1 ]
Zhou, Jiaxiong [1 ]
机构
[1] Zhongshan City Peoples Hosp, Dept Oncol Radiotherapy, 2 Sunwen Middle Rd, Zhongshan 528403, Guangdong, Peoples R China
关键词
Xerostomia; Nasopharyngeal carcinoma; Prediction; INTENSITY-MODULATED RADIOTHERAPY; QUALITY-OF-LIFE; NECK-CANCER-PATIENTS; RADIATION-THERAPY; HEAD; OUTCOMES; SALIVA; CHEMORADIATION; TOXICITY; PATTERNS;
D O I
10.1186/s12903-022-02269-0
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background This study was to evaluate the predictors of xerostomia and Grade 3 xerostomia in locoregionally advanced nasopharyngeal carcinoma (NPC) patients receiving radical radiotherapy and establish prediction models for xerostomia and Grade 3 xerostomia based on the predictors. Methods Totally, 365 patients with locoregionally advanced NPC who underwent radical radiotherapy were randomly divided into the training set (n = 255) and the testing set (n = 110) at a ratio of 7:3. All variables were included in the least absolute shrinkage and selection operator regression to screen out the potential predictors for xerostomia as well as the Grade 3 xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy. The random forest (RF), a decision tree classifier (DTC), and extreme-gradient boosting (XGB) models were constructed. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), area under the curve (AUC) and accuracy were analyzed to evaluate the predictive performance of the models. Results In the RF model for predicting xerostomia, the sensitivity was 1.000 (95%CI 1.000-1.000), the PPV was 0.990 (95%CI 0.975-1.000), the NPV was 1.000 (95%CI 1.000-1.000), the AUC was 0.999 (95%CI 0.997-1.000) and the accuracy was 0.992 (95%CI 0.981-1.000) in the training set. The sensitivity was 0.933 (95%CI 0.880-0.985), the PPV was 0.933 (95%CI 0.880-0.985), and the AUC was 0.915 (95%CI 0.860-0.970) in the testing set. Hypertension, age, total radiotherapy dose, dose at 50% of the left parotid volume, mean dose to right parotid gland, mean dose to oral cavity, and course of induction chemotherapy were important variables associated with the risk of xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy. The AUC of DTC model for predicting xerostomia was 0.769 (95%CI 0.666-0.872) in the testing set. The AUC of the XGB model for predicting xerostomia was 0.834 (0.753-0.916) in the testing set. The RF model showed the good predictive ability with the AUC of 0.986 (95%CI 0.972-1.000) in the training set, and 0.766 (95%CI 0.626-0.905) in the testing set for identifying patients who at high risk of Grade 3 xerostomia in those with high risk of xerostomia. Conclusions An RF model for predicting xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy and an RF model for predicting Grade 3 xerostomia in those with high risk of xerostomia showed good predictive ability.
引用
下载
收藏
页数:13
相关论文
共 50 条
  • [31] Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma
    Liang, Zibin
    Wang, Siyang
    Lin, Zhong
    Feng, Shaoyan
    Cheng, Zhibin
    Yang, Yaqi
    Kuang, Ying
    Fidelis, Chibhabha
    Ullah, Shahid
    Li, Feng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) : 643 - 651
  • [32] Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy
    Cheng, SH
    Jian, JJM
    Tsai, SYC
    Chan, KY
    Yen, LK
    Chu, NM
    Tan, TD
    Tsou, MH
    Huang, AT
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (04): : 755 - 762
  • [33] Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
    Zhang, Yuan
    Sun, Ying
    Ma, Jun
    CANCER COMMUNICATIONS, 2019, 39
  • [34] Is chemotherapy beneficial in the treatment of locoregionally advanced nasopharyngeal carcinoma?
    Wong, JR
    CANCER, 1998, 83 (11) : 2255 - 2258
  • [35] A Radiomics-Based Model to Identify Candidates for DeIntensified Treatment in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
    Lin, Y.
    Zhai, T.
    Lin, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E304 - E304
  • [36] A longitudinal assessment of major mouthwashes used in alleviating pain and xerostomia among advanced nasopharyngeal carcinoma patients receiving chemoradiotherapy
    Mageswaran, Rhubain
    Ang, Zen Yang
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [37] A Phase II Study Of Concurrent Nimotuzumab And Intensity-Modulated Radiotherapy In Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
    Feng, Y.
    Cao, C.
    Jiang, F.
    Jin, Q.
    Jin, T.
    Huang, S.
    Hu, Q.
    Chen, Y.
    Piao, Y.
    Hua, Y.
    Feng, X.
    Chen, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E789 - E790
  • [38] Radiotherapy in advanced nasopharyngeal carcinoma
    Tan, C. K.
    Wong, Y. F.
    Khoo, J. Y-Y.
    Jye, V. Pei
    Lau, F. N.
    ANNALS OF ONCOLOGY, 2020, 31 : S1354 - S1354
  • [39] Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
    Hu, Jiyi
    Huang, Qingting
    Gao, Jing
    Guan, Xiyin
    Hu, Weixu
    Yang, Jing
    Qiu, Xianxin
    Chen, Mingyuan
    Kong, Lin
    Lu, Jiade J.
    CANCER, 2020, 126 (23) : 5173 - 5183
  • [40] A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy
    Yi, Hong-Mei
    Yi, Hong
    Zhu, Jin-Feng
    Xiao, Ta
    Lu, Shan-Shan
    Guan, Yong-Jun
    Xiao, Zhi-Qiang
    TUMOR BIOLOGY, 2016, 37 (03) : 2941 - 2949